Detalhe da pesquisa
1.
Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolution.
Histopathology
; 74(4): 654-662, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30393995
2.
Bendamustine-based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers.
Am J Hematol
; 93(6): 729-735, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29473209
3.
Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case retrospective study from LYSA and the LOC network.
Haematologica
; 100(9): 1199-206, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26185174
4.
FDG-PET/CT is a pivotal imaging modality to diagnose rare intravascular large B-cell lymphoma: case report and review of literature.
Hematol Oncol
; 33(2): 99-109, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24850057
5.
Hepatocellular carcinoma complicating hepatitis E virus-related cirrhosis.
Hepatology
; 67(1): 446-448, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28873236
6.
Brentuximab vedotin followed by allogeneic transplantation as salvage regimen in patients with relapsed and/or refractory Hodgkin's lymphoma.
Hematol Oncol
; 32(4): 187-91, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24301099
7.
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor.
Am J Hematol
; 89(1): 83-7, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24108528
8.
Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma.
Am J Hematol
; 88(5): 370-4, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23460414
9.
A phase II study of lenalidomide and rituximab (R2) combination in patients with high-risk refractory/relapsed diffuse large B-cell lymphoma.
Hematology
; 28(1): 2207948, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133334
10.
Primary B-CLL resistance to NK cell cytotoxicity can be overcome in vitro and in vivo by priming NK cells and monoclonal antibody therapy.
J Clin Immunol
; 32(3): 632-46, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22318393
11.
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy.
Haematologica
; 97(7): 1073-9, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22271893
12.
Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myeloma.
Eur J Haematol
; 88(6): 497-503, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22385049
13.
Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study.
J Clin Oncol
; 40(10): 1091-1101, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34990281
14.
Full access to medical records does not modify anxiety in cancer patients: results of a randomized study.
Cancer
; 117(20): 4796-804, 2011 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21607939
15.
Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patients.
Haematologica
; 100(10): e423-7, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26206800
16.
Bing-Neel syndrome: a cerebral Richter syndrome?
Neurol India
; 62(2): 229-30, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24823755
17.
Features and risk factors of peripheral neuropathy during treatment with bortezomib for advanced multiple myeloma.
Clin Lymphoma Myeloma
; 8(3): 146-52, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18650177
18.
CDKN2A/B Deletion and Double-hit Mutations of the MAPK Pathway Underlie the Aggressive Behavior of Langerhans Cell Tumors.
Am J Surg Pathol
; 42(2): 150-159, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29194093
19.
[Hodgkin and non-Hodgkin lymphoma of adolescents and young adults]. / Lymphomes hodgkiniens et non hodgkiniens des adolescents et des jeunes adultes.
Bull Cancer
; 103(12): 1035-1049, 2016 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-27866679
20.
Lenalidomide for the treatment of B-cell lymphoma.
Expert Opin Investig Drugs
; 25(9): 1103-16, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27414850